Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib

Author：                              

Publisher： Science Publishers

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.3, Iss.4, 2015-01, pp. : 802-806

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC)

By Ferrigno D.   Buccheri G.   Giordano C.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 311-320

Elsevier

Access to resources Recommend Favorite

Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy

By Wang Lei   Meng Long   Wang Xing-wen   Ma Guo-yuan   Chen Jing-han  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 1899-1906

Springer Publishing Company

Access to resources Recommend Favorite

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib

By Wang Fenghua  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 331-335

Humana Press, Inc

Access to resources Recommend Favorite

High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer

By Choi In Keun   Kim Yeul Hong   Kim Jun Suk   Seo Jae Hong  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 861-864

Informa Healthcare

Access to resources Recommend Favorite

Neuroepithelial transforming gene 1 functions as a potential prognostic marker for patients with non-small cell lung cancer

By            

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 7439-7446

Spandidos Publications

Access to resources Recommend Favorite